Registration Dossier
Registration Dossier
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 287-401-6 | CAS number: 85507-79-5
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation
- Remarks:
- in vivo
- Type of information:
- migrated information: read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Study period:
- 1999
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Descrition of a well conducted human study reported in a peer reviewed journal. For read-across justification see Section 13.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 999
Materials and methods
Test guideline
- Qualifier:
- no guideline available
- Principles of method if other than guideline:
- DUP was tested in a 104 person panel human repeated insult patch test (HRIPT) using the modified Draize procedure.
- GLP compliance:
- not specified
- Remarks:
- Not applicable
- Type of study:
- other: Human repeated insult patch test
Test material
- Reference substance name:
- Diundecyl phthalate
- EC Number:
- 222-884-9
- EC Name:
- Diundecyl phthalate
- Cas Number:
- 3648-20-2
- Molecular formula:
- C30H50O4
- IUPAC Name:
- diundecyl benzene-1,2-dicarboxylate
- Details on test material:
- - Name of test material (as cited in study report): diundecyl phthalate
- Physical state: liquid
- Analytical purity: >99.0 % based on product specification for DUP
Constituent 1
In vivo test system
Test animals
- Species:
- human
- Strain:
- not specified
- Sex:
- male/female
- Details on test animals and environmental conditions:
- N/A human study
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- undiluted DUP at 100% concentration
Challengeopen allclose all
- Route:
- epicutaneous, occlusive
- Vehicle:
- unchanged (no vehicle)
- Concentration / amount:
- undiluted DUP at 100% concentration
- No. of animals per dose:
- 104 male & female individuals
- Details on study design:
- RANGE FINDING TESTS: yes; irritation test in 14 female & 1 male subjects with undiluted DUP applied to a cotton pad covered by hypoallergenic tape. Responses evaluated 30 minutes & 24h after patch removal
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: 9, with a 24h contact period on each occasion
- Exposure period: a 24h contact period on each occasion
- Test groups: 1
- Control group: no
- Site: deltoid area of the arm
- Frequency of applications: 3 X weekly (Monday, Wednesday & Fri) for 3 weeks
- Duration: 72h (reactions scored 48 or 72h after each induction application)
- Concentrations: 100% undiluted DUP
B. CHALLENGE EXPOSURE
- No. of exposures: 1 (following 10-17 day recovery period) in wk 6
- Day(s) of challenge: 1
- Exposure period: 24h
- Test groups: No
- Control group: No
- Site: Naive site
- Concentrations: 0.2 ml 100% undiluted DUP
- Evaluation (hr after challenge): 48 & 96h - Challenge controls:
- None
- Positive control substance(s):
- no
Study design: in vivo (LLNA)
- Statistics:
- No data
Results and discussion
- Positive control results:
- N/A
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 0.2 ml 100 % undiluted DUP
- No. with + reactions:
- 0
- Total no. in group:
- 104
- Clinical observations:
- None reported
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 48.0. Group: test group. Dose level: 0.2 ml 100 % undiluted DUP. No with. + reactions: 0.0. Total no. in groups: 104.0. Clinical observations: None reported.
- Reading:
- 2nd reading
- Hours after challenge:
- 96
- Group:
- test chemical
- Dose level:
- 0.2 ml 100 % undiluted DUP
- No. with + reactions:
- 0
- Total no. in group:
- 104
- Clinical observations:
- None reported
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 96.0. Group: test group. Dose level: 0.2 ml 100 % undiluted DUP. No with. + reactions: 0.0. Total no. in groups: 104.0. Clinical observations: None reported.
Applicant's summary and conclusion
- Interpretation of results:
- not sensitising
- Remarks:
- Migrated information
- Conclusions:
- Under the conditions of this HRIPT< following treatment with undiluted 100% DUP, there was no evidence of skin irritation (dose range finding study) or sensitisation (main study) in any of the 104 panelists who completed the study.
- Executive summary:
A human repeat insult patch test (HRIP) with the undiluted substance resulted in no evidence of sensitisation in any of the 104 panelists who completed the study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
